Patient with hepatic cirrhosis: management strategy according to national clinical guidelines and real clinical practice. Results of a retrospective cohort study


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Background. The immediate causes of death in patients with hepatic cirrhosis (HC) include infectious complications, hepatic encephalopathy (HE), and variceal hemorrhage. In real clinical practice, low adherence to the medical care quality criteria for this complex population of patients remains, which cannot but affect the results of treatment. Objective. Optimization of the management tactics for HC patients based on assessment of practitioners’ adherence to national clinical guidelines and their compliance with the medical care quality criteria. Methods. A retrospective cohort study based on a review of 589 medical records of patients with HC who were examined and treated in outpatient and inpatient settings in 2015-2020 at the Central Hospital of the Krasnodar Territory was conducted. Medical records of outpatients and medical records of inpatients with HC complications and receiving drug therapy were reviewed. Results. The most frequent HC complications were ascites (in 51.8% of patients) and variceal hemorrhage (in 26.1%). At the outpatient stage, control of the water-electrolyte balance was carried out only in 134 (66.7%) patients with ascites, adequate diagnostic measures were carried out for 65 (77.3%) patients with clinically significant HE, 19 (22.6%) patients did not receive course therapy in the presence of clinical manifestations of HE. Screening esophagogastroduodenoscopies at the outpatient stage were regularly performed in only 61.5% of patients with clinically significant portal hypertension. At the inpatient stage, adherence to the medical care quality criteria for patients with ascites did not exceed 76.9%, with spontaneous bacterial peritonitis - 2.6%, HE - 73.0%; in case of diagnosing and treating variceal hemorrhage it ranged from 4.2% to 94.4%. Conclusion. The study revealed a number of errors in the management tactics of patients with HC at the outpatient and inpatient stages of medical care, affecting the results of treatment.

Толық мәтін

Рұқсат жабық

Авторлар туралы

N. Korochanskaya

Kuban State Medical University; Regional Clinical Hospital № 2

Email: nvk-gastro@mail.ru
Krasnodar, Russia

V. Durleshter

Kuban State Medical University; Regional Clinical Hospital № 2

Krasnodar, Russia

O. Kovalevskaya

Regional Clinical Hospital № 2

Krasnodar, Russia

M. Basenko

Kuban State Medical University; Regional Clinical Hospital № 2

Krasnodar, Russia

S. Serikov

Kuban State Medical University; Regional Clinical Hospital № 2

Krasnodar, Russia

Әдебиет тізімі

  1. Hudson B., Round J., Georgeson B., et al. Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England. Lancet Gastroenterol Hepatol. 2018;3:95-103. doi: 10.1016/S2468- 1253(17)30362-X.
  2. Tapper E.B., Halbert B., Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study. Clin Gastroenterol Hepatol. 2016;14:1181- 1188, e1182. doi: 10.1016/j.cgh.2016.04.009
  3. Ивашкин В.Т., Маевская М.В., Павлов Ч.С., и др. Клинические рекомендации Российского общества по изучению печении Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, коло-проктологии. 2016;26(4):71-102
  4. European Association for the Study of the Liver; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-60. Doi: W.1016/j.jhep.2018.03.024.
  5. Le S, Spelman T, Chong C.P, et al. Could adherence to quality of care indicators for hospitalized patients with cirrhosis-related ascites improve clinical outcomes? Am J Gastroenterol. 2016;111(1):87-92. doi: 10.1038/ajg.2015.402.
  6. Landis C.S, Ghabril M., Rustgi V, et al. Prospective multicenter observational study of overt hepatic encephalopathy. Dig Dis Sci. 2016;61:1728-1734.
  7. Wooller K.D., Yelle D, Fisher S., et al. Adherence to quality indicators and hospital outcomes for patients with decompensated cirrhosis: An observational study. Canadian Liv J. 2020;4:348-57. doi: 10.3138/canlivj-2020-0003.
  8. Polis S., Zang L., Mainali B., et al. Factors associated with medication adherence in patients living with cirrhosis. J Clin Nurs. 2016;25:204-12. doi: 10.1111/jocn.13083.
  9. Garcia-Tsao G., Abraldes J.G., Berzigotti A., Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310-35. Doi: 10.1002/ hep.28906.
  10. Shukla R., Kramer J., Cao Y, et al. Risk and predictors of variceal bleeding in cirrhosis patients receiving primary prophylaxis with non-selective beta-blockers. Am J Gastroenterol. 2016;111:1778-1787. doi: 10.1038/ajg.2016.440.
  11. Bajaj J.S., Reddy K.R., Tandon P, et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200-8. doi: 10.1002/hep.28414.
  12. Tapper E.B., Finkelstein D. Mittleman M.A., et al. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;14(5):753-59. doi: 10.1016/j.cgh.2015.08.041. Medline: 26407750.
  13. Sobotka L.A., Modi R.M., Vijayaraman A., et al. Paracentesis in cirrhotics is associated with increased risk of 30-day readmission. World J Hepatol. 2018;10(6):425-32. Doi: 10.4254/ wjh.v10.i6.425. Medline: 29988878.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>